Myotonic Dystrophy Type 1 (DM1) Clinical Trials in Richmond, Virginia
4 recruitingRichmond, Virginia
Showing 1–4 of 4 trials
Recruiting
Phase 3
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
Myotonic DystrophyDM1Steinert Disease+2 more
Dyne Therapeutics150 enrolled19 locationsNCT07486934
Recruiting
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1) Extension
Myotonic DystrophyMyotonic Dystrophy 1Myotonic Dystrophy Type 1+3 more
Virginia Commonwealth University1,000 enrolled1 locationNCT07700225
Recruiting
Phase 1Phase 2
A Phase 1/2 Study of VX-670 in Adult Participants With Myotonic Dystrophy 1 (DM1)
Myotonic Dystrophy Type 1 (DM1)
Vertex Pharmaceuticals Incorporated52 enrolled26 locationsNCT06185764
Recruiting
Phase 1Phase 2
Safety, Tolerability, Pharmacodynamic, Efficacy, and Pharmacokinetic Study of DYNE-101 in Participants With Myotonic Dystrophy Type 1
Myotonic Dystrophy Type 1 (DM1)
Dyne Therapeutics116 enrolled20 locationsNCT05481879